Strong language: Gottlieb upgrades youth use from ‘epidemic’ to ‘tragedy’

The language used by US Food and Drug Administration (FDA) commissioner Scott Gottlieb to describe youth vaping is getting stronger. What he formerly called an “epidemic” has become a “tragedy” in his first statement on the issue since Altria announced they would stop selling e-cigarette pods and many flavours.

Gottlieb today described as “constructive” recent meetings with Juul Labs, Altria, Reynolds American, Fontem Ventures and Japan Tobacco International. The meetings followed letters sent by the FDA on 12th October to 21 manufacturers and importers requesting information on more than 40 products.

The commissioner said the company’s proposals were “thoughtful”. And he added: “We’re committed to announcing a new action plan by mid-November that will set forth a series of new, forceful steps to firmly confront and reverse the youth addiction trends that are at epidemic levels.”

Read full article
I'm already a subscriber
Author default picture

Daniel Mollenkamp

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization